ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
May 31, 2021 Cover
Volume 99, Issue 20
C&EN tries out the new batch of at-home COVID-19 tests promising quick results with minimal exposure, enabling some people to get back to school and back to work.
Cover image:C&EN tries out the new batch of at-home COVID-19 tests available in the US, which promise quick results while minimizing exposure
Credit: Kim Leeson
C&EN tries out the new batch of at-home COVID-19 tests promising quick results with minimal exposure, enabling some people to get back to school and back to work.
SARS-CoV-2 variants are emerging and gaining traction around the world. What does that mean for our vaccines and treatments for COVID-19?
Pharmaceutical services firm emerges from selling its viral vector business with a clean balance sheet and record sales
New XPS panels are replacing HFC-134a with HFO blends for a big greenhouse gas reduction
The graphic artist’s Carbon illustrates an element’s journey from a star to his brain
Another biological macromolecule has been found to get some sweet additions; researchers say glyco-RNAs could help in immune signaling